Stem Cell Therapy in Spain: Legal Framework, Clinics, and What Americans Should Expect

Stem cell therapy is legal in Spain, but only inside a strict framework: Spain regulates stem cells as a medicine, not as a procedure a clinic can simply offer. A treatment must be an authorized advanced therapy medicinal product, part of an approved clinical trial, or delivered under a specific hospital exemption granted by the Spanish Medicines Agency. That is narrower than what many American patients are shown online — and it is precisely why Spain is one of the safer places to ask the question.

Is Stem Cell Therapy Legal in Spain?

Yes, and the answer is short because Spain classifies stem cells as a drug. Under EU Regulation (EC) No 1394/2007, any product based on cells that have been substantially manipulated, or used for a different essential function than they served in the donor, is an Advanced Therapy Medicinal Product (ATMP). ATMPs are medicines. They require formal authorization, pharmaceutical-grade manufacturing, traceability from donor to patient, and ongoing safety monitoring.

Oversight in Spain sits with the AEMPS — the Agencia Española de Medicamentos y Productos Sanitarios. Spanish Royal Decree 477/2014 additionally created a route for advanced therapies that are not industrially manufactured, commonly called the hospital exemption. It allows a named hospital to produce a therapy for specific patients under an AEMPS-approved technical data sheet, rather than a full EU-wide marketing authorization.

In practice, there are three lawful ways to receive a stem cell therapy in Spain:

• An authorized ATMP — a product with marketing authorization granted through the European Medicines Agency and the European Commission.
• An approved clinical trial — authorized by AEMPS and cleared by an independent research ethics committee.
• Hospital exemption under RD 477/2014 — non-routine use, at a named hospital, with AEMPS authorization.

What is not lawful is a commercial clinic selling unregulated stem cell infusions for chronic disease outside of those three routes. If a clinic in Spain offers you that, the problem is not the price. It is that the offer itself sits outside the law.

Which Stem Cell Therapies Are Actually Approved in Europe?

Far fewer than the marketing suggests. Since the first advanced therapy launched in the EU in 2009, roughly two dozen ATMPs have been approved across the entire European market — and only a subset of those are stem cell based. The landmark cases are worth knowing:

• Holoclar — the first stem cell–based medicinal product to receive conditional marketing authorization in the EU. It uses a patient’s own limbal stem cells to repair the cornea after physical or chemical eye burns, treating moderate to severe limbal stem cell deficiency.
• CAR-T therapies — engineered immune cell treatments for certain blood cancers, now an established part of European hematology.
• ARI-0001 — developed at Hospital Clínic de Barcelona and authorized by AEMPS in February 2021 under the hospital exemption pathway. It was the first academic CAR-T authorized in Europe, and it is a genuine marker of Spanish capability: a Spanish public hospital took a therapy from bench to authorized clinical use.
• Alofisel (darvadstrocel) — an allogeneic mesenchymal stem cell therapy for complex perianal fistulas in Crohn’s disease, originally developed in Spain and authorized in the EU in 2018. Its marketing authorization was withdrawn on 13 December 2024 after the ADMIRE-CD II trial failed to meet its primary endpoint and the clinical benefit was no longer considered demonstrated.

At Heal in Spain, we think that last example is the single most useful thing an American patient can hear. A therapy was approved, studied further, failed to prove its benefit, and was pulled from the market. That is not a failure of the system — that is the system. Any clinic that has never had to update its claims in light of new evidence should make you curious about what evidence it is using.

What Spain Genuinely Does at Scale

There is one area of stem cell medicine where Spain is not experimental at all: hematopoietic stem cell transplantation, better known as bone marrow transplant. The volumes are substantial and publicly reported by the Organización Nacional de Trasplantes (ONT), the national transplant authority.

• 3,844 hematopoietic stem cell transplants were performed in Spain in 2024.
• 2,246 (58%) used the patient’s own cells (autologous).
• 1,598 (42%) were made possible by a donor (allogeneic).
• 748 came from unrelated volunteer donors — the highest number ever recorded in Spain.
• 426 Spaniards donated bone marrow to a stranger during 2024.
• Spain has led the world in deceased organ donation rates for more than three decades, under the same national coordination model.

This matters for context. Spain’s infrastructure for handling human cells — donor registries, traceability, transplant units, immunology support — is mature and heavily audited. That is a different claim from «Spain will give you stem cells for your knee,» and the distinction is the whole point.

What Should Americans Ask Before Booking Anything?

American patients are used to a market where the U.S. Food and Drug Administration has repeatedly warned about clinics marketing unapproved stem cell products. The instinct to travel for something better is understandable. The questions below travel well:

• Which of the three lawful routes is this? Authorized product, clinical trial, or hospital exemption. If the clinic cannot name one, stop.
• What exactly is being administered? «Stem cells» is not an answer. Cell type, source, dose, and manipulation should be documented.
• Who is the treating physician, and what is their specialty? A named, licensed Spanish specialist should own your case.
• What does the published evidence show for my specific condition? Not for the technology in general.
• What happens if it doesn’t work, or if there is a complication back home? Aftercare planning is not optional.
• Is a second opinion welcome? A confident clinic says yes immediately.

If a clinic guarantees results, treats a long list of unrelated conditions with the same infusion, requires large payment up front, or discourages you from consulting your own physician, those are the classic warning signs. We would rather you ask a second opinion question and lose a week than pay for something that was never going to help.

What Is Realistically Available in Alicante Today?

Most of what is offered commercially under the «regenerative medicine» heading in Spain is not stem cell therapy in the ATMP sense. Platelet-rich plasma (PRP), growth factor preparations, and other orthobiologic injections sit in a different regulatory category because the cells are minimally manipulated and used for their original function. The evidence for these is mixed but real in specific orthopedic indications — certain tendon and joint problems — and honest clinics describe them that way rather than as a cure.

We cover what is actually offered locally in our guide to regenerative medicine and anti-aging treatments in Alicante. If you are weighing Spain against other destinations for this kind of care, our comparison of Alicante versus other medical tourism destinations explains why regulatory strictness is a feature, not an obstacle.

Key Takeaways

• Spain regulates stem cells as medicines under EU ATMP rules, with AEMPS as the national authority.
• Only three lawful routes exist: an authorized product, an approved clinical trial, or a hospital exemption under Royal Decree 477/2014.
• Approved stem cell–based products in Europe remain a short list; Holoclar and the Barcelona-developed CAR-T ARI-0001 are the reference cases.
• The 2024 withdrawal of Alofisel shows European regulators removing a therapy when the evidence did not hold.
• Spain performed 3,844 hematopoietic stem cell transplants in 2024 — this is where Spanish cell medicine operates at genuine scale.
• Most commercial «regenerative» offerings are PRP and orthobiologics, which is a different category and should be described honestly.

If you are considering travel to Spain for regenerative or advanced therapy care, the useful first step is not choosing a clinic. It is getting an honest read on whether the treatment you are considering exists in an approved form for your condition at all. At Heal in Spain, we assign every patient a Spanish physician who reviews the case before anything is booked, and we will tell you plainly when the answer is no. If you would like to see how a trip is normally structured, our step-by-step medical travel timeline walks through the full process, and you can read more about our services at healinspain.com.

Talk It Through With Us

A short conversation usually saves a long detour. If you have been offered a stem cell treatment and want a straight answer about what it is and whether it is regulated in Spain, we are happy to look at it with you — no obligation, and no pressure to travel.

• Call our U.S. line: +1 645 248 8622 — dial directly from anywhere in the United States, no international prefix needed.
• Call our Spain line: +34 658 33 51 50
• Email: info@healinspain.com
• Web: healinspain.com

This article is general information about the regulatory landscape in Spain and is not medical advice. Decisions about advanced therapies should be made with a licensed physician who has reviewed your full medical history.